COCCNC(=S)N(C)[C@H]1C[C@H]2c3cc(Oc4ccccc4C)ccc3CCN2C(=O)[C@H]1[C@H](C)O
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?